Effectively Using Contamination Control Strategies

Developing an Effective Contamination Control Strategy

In this article, RCA expert and Susan J. Schniepp of Regulatory Compliance Associates (RCA), a Nelson Labs company, discuss how contamination control strategies (CCSs) support pharmaceutical manufacturing quality, patient safety, and regulatory compliance. A CCS provides a comprehensive, proactive approach to identifying, assessing, and controlling contamination risks while supporting continuous improvement across manufacturing operations.

The article highlights key components of an effective CCS, including personnel and environmental monitoring, process and equipment validation, cleaning and sanitization, personnel training, and quality risk management. A strong quality culture and scientifically grounded controls are essential to maintaining effective contamination prevention practices. The experts also emphasize the importance of aligning contamination control efforts with applicable regulatory expectations, including EU GMP Annex 1 and relevant FDA and ICH guidance.

Risk assessment is a fundamental part of a successful CCS, helping manufacturers identify potential contamination sources, evaluate their impact, and prioritize preventive measures. By integrating risk-based decision-making, cross-functional collaboration, and ongoing process improvement, organizations can strengthen contamination controls, improve product quality, and protect patient safety.

Read the full article: Developing an Effective Contamination Control Strategy.